Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma by Xin Zhu et al.
Zhu et al. Journal of Experimental & Clinical Cancer Research  (2014) 33:114 
DOI 10.1186/s13046-014-0114-5RESEARCH Open AccessPim-1 acts as an oncogene in human salivary
gland adenoid cystic carcinoma
Xin Zhu1†, Jia-jie Xu2†, Si-si Hu2, Jian-guo Feng1, Lie-hao Jiang2, Xiu-xiu Hou2, Jun Cao2, Jing Han1,
Zhi-qiang Ling1 and Ming-hua Ge2*Abstract
Background: Pim-1 (Provirus integration site for Moloney murine leukemia virus 1) belongs to the Ser/Thr kinase
family and plays a pivotal role in occurrence and development of oncogenesis. Recent studies have demonstrated
that Pim-1 phosphorylates RUNX3 and alters its subcellular localization. However, few studies have concerned the
implications of Pim-1 in the salivary gland adenoid cystic carcinoma (ACC). In this study, we aimed to clarify the
function of Pim-1 in ACC in vitro. Meanwhile, we measured the levels of Pim-1 and RUNX3 in the ACC tissues. The
correlations between Pim-1/RUNX3 levels and clinical parameters were also analyzed.
Methods: SACC-83 and SACC-LM cells were transfected with the Pim-1 siRNA. Pim-1 mRNA and protein expression
were measured using real-time PCR and immnuoblot, respectively. Cell proliferation was analyzed by CCK-8 assay.
Cell cycle, apoptosis, and mitochondrial membrane potential were detected by flow cytometry. Effects of Pim-1 on
cells’ invasion were evaluated by transwell migration assay. Pim-1 and RUNX3 levels in ACC tissues were examined
by immunohistochemistry.
Results: Pim-1 siRNA reduces cell proliferation, induces apoptosis, causes cell cycle arrest through cell cycle related
proteins (Cyclin D1 and CDK4), mitochondrial depolarization, and decreases invasive ability in SACC-83 and SACC-LM
cells. Pim-1 and RUNX3 levels are significantly relevant and associated with T-stage and nerve invasion in the ACC
tissues.
Conclusions: This study demonstrates the oncogenic role of Pim-1 in ACC. The findings also suggest that Pim-1 may
serve as a neoteric therapeutic target and potential prognostic marker for ACC cancer.
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Salivary gland adenoid cystic carcinoma (ACC) accounts
for approximately 10% of all epithelial salivary tumors.
Clinical characteristics of ACC include high aggressive
to nerve and vessel, high rate of recurrence, and fre-
quent metastasis to lung. The 5-year survival rate of pa-
tients with highly metastatic ACC is less than 20%. Since
ACC is not sensitive to radiotherapy or chemotherapy, sur-
gical resection is the most common treatment for ACC.
Like most other tumors, the interaction of oncogenes and
tumor suppressor genes is involved in the development of
ACC. However, the precise mechanism responsible for its* Correspondence: gemingh@163.com
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unless otherwise stated.oncogenesis is not completely understood [1-3]. Therefore,
it is warranted to study the molecular mechanism of saliv-
ary gland ACC to gain insight into its diagnosis, prognosis,
and treatment.
As a widely accepted tumor suppressor gene, RUNX3
(human runt-related transcription factor 3) functions in
major physiological and pathological processes. Many re-
ports have shown essential behavior of RUNX3 in a var-
iety of cancers [4]. Our previous study presented the
expression of RUNX3 in normal salivary glands and sal-
ivary ACC. Moreover, the expression of RUNX3 is obvi-
ously correlated with histopathological growth pattern, T
stage, distant metastasis, and patient’s survival. These re-
sults suggested that the low level of RUNX3 in salivary
gland ACC might play a key role in tumor progression
and have prognostic value in ACC [5]. Subsequently, weis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the progression of the ACC by laser scanning confocal
microscope [6].
Recent studies have demonstrated that Pim-1, which
acted as an oncogene, could phosphorylate RUNX3 and
alter its subcellular localization [7,8]. As belongs to the
Ser/Thr kinase family, Pim kinases can phosphorylate a
large range of cellular substrates to exert their physio-
logical activities, which are involved in cell differenti-
ation, cell proliferation, cell cycle and apoptosis. Pim-1
plays a pivotal role in tumorigenesis and overexpression
of it has been implicated in several cancers [9,10]. Col-
lectively, these reports suggest that Pim-1’s function is
important in the progression of cancer.
However, the oncogenic role of Pim-1 in ACC has not
yet been examined. As an effective tool to achieve gene
silence, small interfering RNAs (siRNAs) were used in
lots of researches to clarify the gene function [11-13]. In
this study, using siRNA transfection in vitro, we aim to
clarify the gene function of Pim-1 in ACC through the
detection of cell proliferation, cell cycle, cell apoptosis
and cell invasion. Meanwhile, a Pim-1 inhibitor (SGI-
1776) was used to confirm the affection of Pim-1 on the
cell proliferation ability. The RUNX3, Cyclin D1 and
CDK4 (cyclin-dependent kinase 4) expression after Pim-
1 siRNA transfection was investigated as well. Further-
more, the relationship between Pim-1 and RUNX3 was
deduced in the ACC tissues. The correlation of Pim-1/
RUNX3 and clinical parameters were analyzed. This
study provided new data of Pim-1 activity in ACC and is
suggestive that Pim-1 has potential to become a tumor
marker as well as a therapy target of cancer.
Materials and methods
Tissue specimens
Fifty-four patients with histopathologically proven saliv-
ary gland adenoid cystic carcinoma (ACC) in Zhejiang
Cancer Hospital between July 2006 and July 2010 were
included for this study. The study was approved by the
Ethics Committee of Zhejiang Cancer Hospital, and pa-
tients have signed informed consent.
Cell culture and siRNA transfection
SACC-83 and SACC-LM were kind gifts from Prof. Li
Shengling (Peking University School of Stomatology).
SACC-83 is derived from human ACC tissue and SACC-
LM is a lung metastasis cell line of SACC-83 [14,15]. It
is considered that SACC-LM is more malignant then
SACC-83. Both cell lines were cultured in RPMI-1640
(Gibco, USA) supplemented with 10% fetal bovine serum
(FBS) (HyClone Laboratories, Logan, USA) in a humidi-
fied atmosphere of 5% CO2 at 37°C. Pim-1 siRNA and
control siRNA were obtained from Santa Cruz Company
(CA, USA). SACC-83 and SACC-LM cells were seededin a 96-well culture plate with a density of 5 × 103 cells/
well or in a 6-well culture plate with a density of 1 × 106
cells/well. After 24 h, siRNAs (0.1 μmol/L) were trans-
fected with Oligofectamine TM Reagent (Invitrogen,
Carlsbad, CA, USA) into the cells according to manufac-
turer's protocol.
SGI-1776 treatment
SGI-1776 (Selleckchem, Houston, TX, USA) was dissolved
in DMSO to obtain a stock solution at 10 mmol/L and
stored at −80°C. After SACC-83 and SACC-LM were cul-
tured, SGI-1776 was added to the culture system to
achieve the final doses of 0–10 μmol/L. The highest con-
centration of DMSO in the culture was 0.1% and we tested
that it had no effect on the cells viability.
Cell proliferation assay
According to manufacturer's instructions, Cell Counting
Kit-8 (CCK-8) was used to determine the cell prolifera-
tion (Dojindo Biotechnology, China). Briefly, SACC-83
and SACC-LM cells were seeded in a 96-well cell plate
for 24 h, and then transfected with Pim-1 siRNA/control
siRNA, for 48 and 72 h and exposed to SGI-1776 for 24,
48 and 72 h respectively. Then the medium were dis-
carded and replaced with 100 μl of fresh medium con-
taining 10% CCK-8. After cells were incubated at 37°C
for 4 h, the absorbance was detected at 450 nm on a mi-
croplate reader.Colony formation assay
After transfected with Pim-1 siRNA and control siRNA
for 72 h, SACC-83 and SACC-LM cells were washed
with PBS (Phosphate Buffer Solution) and trypsined.
Then the cells were seeded into a 12-well plate with a
density of 500 cells/ well. After 7 days of incubation, col-
onies were stained by 0.5% crystal violet (Sigma-Aldrich,
St. Louis, MO, USA) and counted directly.Evaluation of live cell undergoing apoptosis
In this study, Annexin V-FITC and propidium iodide
(PI) (BD Biosciences, USA) were used to distinguish in-
tact, dead and apoptotic cells by using the flow cytomet-
ric method. SACC-83 and SACC-LM cells were
harvested and washed with cold PBS after transfected
with Pim-1 siRNA and control siRNA for 72 h. Subse-
quently, the cells were resuspended in 100 μL binding
buffer. 5 μL Annexin V-FITC and 1 μL PI were added to
the cell suspension and incubated in darkness at room
temperature for 15 min. Thereafter, 400 μl binding buf-
fer was added to each sample and then the cells were an-
alyzed by using the flow cytometer (BDLSR, Becton
Dickinson, USA).
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Cell cycle assay was performed using the Cycle Test
Plus™ DNA Reagent Kit (340242, Becton Dickinson,
USA) following the manufacturer’s instructions. SACC-
83 and SACC-LM cells were harvested and washed with
cold PBS after transfected with Pim-1 siRNA and control
siRNA for 72 h. Then, the cells were fixed in pre-cooled
70% ethanol for 24 h at 4°C. After that, the cells were dyed
with PI and detected by flow cytometry (BDLSR, Becton
Dickinson, USA) to evaluate the cell cycle distribution.
Transwell chamber invasive assay
After transfected with Pim-1 siRNA and control siRNA
for 72 h, SACC-83 and SACC-LM cells were obtained
and plated at 1.0 × 105 cells/well in 0.5 mL of serum-free
medium in 24-well matrigel-coated transwell units with
polycarbonate filters (8 μm pore size; Costar Inc., Milpitas,
CA, USA). The outer chambers were filled with 0.5 mL of
RPMI 1640 medium supplemented with 10% FBS. After
incubated for 24 h, the cells were fixed in methanol and
stained with 2% crystal violet. The top surface of the
membrane was gently removed and the invading cells
were counted in five randomly selected fields under a
microscope.
Assessment of mitochondrial membrane potential
The mitochondrial membrane potential (MMP), which
is recognized as a typical marker of early apoptosis was
measured by the fluorescent probe JC-1 (MultiSciences
Company, Hangzhou, China) in this study. As a cationic
and lipophilic dye, JC-1 presents a fluorescence emission
shift from green (525 nm) to red (590 nm) to indicate
the potential-dependent accumulation in mitochondria.
In healthy and normal cells with low membrane poten-
tials, JC-1 appears as a monomer and produces a green
fluorescence. At high membrane potentials, J aggregates is
induced by JC-1 and the red fluorescence was emerged. In
accordance with the manufacturer's protocol, after SACC-
83 and SACC-LM cells were transfected by the Pim-1
siRNA for 72 h, the cells were harvested, centrifuged and
re-suspended in 1 ml staining buffer. After stained with 1ul
JC-1 staining solutions, the cells were incubated at 37°C in
the dark for 30 min. Subsequently, the cells were washed
twice with warm PBS buffer and re-suspended in 0.5 ml
PBS buffer. Flow cytometry was performed to examine the
red/green fluorescent signals.
Quantitative real-time reverse transcription-PCR
SACC-83 and SACC-LM cells were transfected with
Pim-1 siRNA or control siRNA for 72 h. Total RNA was
extracted by using Trizol (Invitrogen, Carlsbad, CA, USA)
and reverse-transcription was done with PrimeScipt™ RT
reagent Kit (TAKARA BIO INC., Otsu, Shiga, Japan) ac-
cording to manufacturer’s instructions. Quantitative real-time PCR (qRT-PCR) was performed on an ABI Prism
7500 instrument (Applied Biosystems, Foster city, CA,
USA) by using the SYBR Premix Ex Taq (TAKARA BIO
INC., Dalian, China). Pim-1 and GAPDH mRNA levels





After PCR amplification, the dissociation of SYBR
Green-labeled cDNA was carried out to affirm that there
were no nonspecific PCR products. 2-ΔΔCt method was
performed to analyze the relative quantification of Pim-1
expression.
Western blot analysis
SACC-83 and SACC-LM cells were trypsinized and
washed with cold PBS after transfected with Pim-1 siRNA
or control siRNA for 72 h. Then cell pellet was lysed with
RIPA Lysis Buffer (Beyotime, Nanjing, China). ACC tissue
samples were ground with the Tissue Lyser-II (Qiagen,
Germany) and lysed with RIPA Lysis Buffer. Protein con-
centrations were determined by the BCA Protein Assay
Kit (Beyotime, Nanjing, China). All samples were stored
at −70°C prior to electrophoresis. Each sample containing
50 μg of protein were subjected to 12% SDS-PAGE and
separated by electrophoresis. Then the proteins were
transferred electrophoretically from the gel to nitrocellu-
lose membrane (Immobilon-PSQ Transfer Membrane,
Millipore Corporation, Bedford, U.S.A.). To prevent non-
specific binding of reagents, the membranes were blocked
in TBS buffer (50 mM Tris-Cl, 150 mM NaCl, pH 7.6)
containing 5% non-fat dry milk at room temperature for
3 h. Then blotted with primary antibodies of Pim-1
(Novus biologicals, Cambridge, UK) (1:1000 dilution),
RUNX3 (Abgent, San Diego, CA, USA) (1:100 dilution),
Cyclin D1 (Proteintech, Whhan, China) (1:1000 dilution),
CDK4 (Proteintech, Whhan, China) (1:1000 dilution), β-
actin (Abcam, New Territories, HK) (1:200 dilution) and
GAPDH (Huabio Technology, Hangzhou, China) (1:2000
dilution) at 4°C overnight and developed with peroxidase-
labeled secondary antibodies (Huabio Technology,
Hangzhou, China). After that, the membranes were exten-
sive washed in TBST and exposed to 2 mL ECL chemilu-
minescence reagent. The images were captured and
analyzed on the Bio-Rad GelDoc XR.
Immunohistochemistry
Section (4 μm) of paraffin-embedded tissues were cut,
mounted on glass slides (MS-coated glass, Mats-unami,
Oaska, Japan), and dried overnight at 37°C. After depar-
affinization, antigen retrieval in 0.01 M citrate buffer,
and inactivation of endogenous peroxidase activity in 3%
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Figure 1 Effect of Pim-1 siRNA on Pim-1 expression level and cell viability in SACC cells. A. Real time PCR results displayed the Pim-1
mRNA expression in both cell lines. B. Western blot showed the inhibition effect of Pim-1 siRNA on Pim-1 protein levels in both cell lines. The
expression of β-actin was used as a quantitative control. C. CCK-8 assay results of SACC-83 cell after transfected with Pim-1 siRNA for 48 h and
72 h. D. CCK-8 assay results of SACC-LM cell after transfected with Pim-1 siRNA for 48 h and 72 h. Data were showed as mean ± SD. p < 0.05,
*Pim-1 siRNA group compared with control siRNA group.
Figure 2 Clonogenic assay of SACC cells transfected with Pim-1 and control siRNA for 72 h. Cells were cultured for 10 days and stained
with crystal violet in 12 well plate.
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Figure 3 Effect of SGI-1776 on cell viability in SACC-83 and SACC-LM cells. A. CCK-8 assay results of SACC-83 cell after exposed to
0–10 μmol/L SGI-1776 for 24 h, 48 h and 72 h. B. CCK-8 assay results of SACC-LM cell after exposed to 0–10 μmol/L SGI-1776 for 24 h, 48 h and
72 h. Data were showed as mean ± SD. p < 0.05, *0.5-10 μmol/L SGI-1776 groups compared with 0 μmol/L SGI-1776 group.
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lution) and RUNX3 (Abcam, New Territories, HK)
(1:200 dilution) at 4°C overnight. The immunoreactivity
was visualized using a streptavidin–biotin peroxidase
staining kit (Histofine Simple Stain Max PO Multi,
Nichirei, Tokyo, Japan) and DAB solution (Simple Stain
DAB, Nichirei). The results were presented as percentage
of nucleus staining positive cells and the total cells. TheFigure 4 Apoptosis induced by Pim-1 siRNA in SACC cells. A. Contour
Pim-1 and control siRNA transfection for 72 h. B. Early-apoptosis and total-a
and total-apoptosis rates of SACC-LM induced by Pim-1 siRNA. Results wer
control siRNA group.scores of staining results were given as negative and posi-
tive. The criterion was consulted our previous study [16].Statistical analysis
All data were analyzed using SPSS 10.0 software. Results
from in vitro experiments were expressed as mean ±
standard deviations and statistically analyzed by the one-diagram of Annexin-V/PI flow cytometric evaluation of apoptosis after
poptosis rates of SACC-83 induced by Pim-1 siRNA. C. Early-apoptosis
e shown as mean ± SD. p < 0.05, *Pim-1 siRNA group compared with
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Pim-1, RUNX3 levels and clinicopathologic parameters
were analyzed using the X2 test or the Fisher exact test.
Survival analysis was carried out by the Kaplan–Meier
method and significant differences were assessed by
means of the log-rank test. P values < 0.05 were consid-
ered to be statistical significance.Results
Effect of the Pim-1 siRNA on the Pim-1 level
SACC-83 and SACC-LM cells were divided into three
groups including blank, control siRNA, and Pim-1 siRNA
groups. After siRNA transfection, Pim-1 transcript andChannels (FL2-A)
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Figure 5 Effect of Pim-1 siRNA on cell cycle of SACC cells. A. Cell cycle
distribution of SACC-83 cells after Pim-1 siRNA transfection. C. Cell cycle disprotein levels were measured by real-time PCR and Western
blot, respectively. Pim-1 transcript (Figure 1A) and protein
levels (Figure 1B) were significantly decreased after Pim-1
siRNA transfection compared to those of blank and con-
trol siRNA, indicating that Pim-1 siRNA effectively inhib-
ited Pim-1 expression in both cell lines.Effect of Pim-1 RNAi on cell proliferation in SACC-83 and
SACC-LM
After transfection with Pim-1 or control siRNA for 48 h
and 72 h, cell viabilities were determined by using the
CCK-8 assay. Results represented that viabilities of both
cells showed a decreased trend along blank, controlChannels (FL2-A)






























rate measured by FCM analysis after PI staining. B. Cell cycle
tribution of SACC-LM cells after Pim-1 siRNA transfection.
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cant differences between the control siRNA and Pim-1
siRNA groups in the SACC-LM cell (Figure 1C and D).
Meanwhile, the colony formation for both SACC cell
lines after transfected with Pim-1 siRNA was evaluated.
As shown in Figure 2, colonies in SACC-83 and SACC-
LM cells which tranfected with Pim-1 siRNA were
significant reduction compared to those of blank and
control siRNA. These suggested that Pim-1 siRNA could
reduce the proliferation activity in SACC cells.Effect of SGI-1776 on cell proliferation in SACC-83 and
SACC-LM
Figure 3 showed that after exposed to 0, 0.5, 1, 2.5,
5 μmol/L SGI-1776 for 24 h, 48 h and 72 h, the prolifera-
tion rates of SACC cells were decreased in a dose and
time-dependent manner. In both cells, there are significant
differences between the 5, 10 μmol/L groups and control
groups at all the SGI-1776 treatment time points.Effect of the Pim-1 siRNA on the apoptosis
In this study, both early-apoptosis rate (Annexin-V+/PI-)
and total apoptosis rate (Annexin-V+/PI- and Annexin-
V+/PI+) were analyzed to describe the effect of Pim-1
knockdown on apoptosis. Flow cytometry analysis
showed that a majority of cells in the blank group were
intact live cells. After siRNA transfection, apoptosis and
dead cells increased measureably (Figure 4A). The data
demonstrated that both SACC-83 and SACC-LM cells
showed a significant increase in early-apoptosis rate in
Pim-1 siRNA group, compared to control siRNA group
after 72 h transfection (Figure 4B and C). A consistent
trend of total cell apoptosis rates was also observed in
this study. These data demonstrate that Pim-1 siRNA
can dramatically induce apoptosis in SACC cells.Figure 6 Suppressive effect of Pim-1 siRNA on the cell invasion in SA
SACC-LM cells after Pim-1 siRNA transfection for 72 h. B. Quantification of t
siRNA groups, respectively. Results were shownas mean ± SD. p < 0.05, *PimEffect of the Pim-1 siRNA on cells cycle
After transfection with Pim-1 or control siRNA for 72 h,
cell cycles were determined by flow cytometer (Figure 5A).
In SACC-LM cells, the percentage of G0-G1 phase in
Pim-1 siRNA transfected cells was significantly higher
than that in control siRNA transfected cells (73.52% vs
64.99%, p < 0.05), whereas the percentages of G2-M phase
and S phase in Pim-1 siRNA transfected cells were sig-
nificantly lower than those in control siRNA transfected
cells (2.86% vs 8.09%, p < 0.05; 23.62% vs 26.91%, p <
0.05) (Figure 5C). The same tendency was observed in
SACC-83 cells except that there was no significant dif-
ference in the percentage of S phase between Pim-1
siRNA and control siRNA groups (Figure 5B). The re-
sults indicated that the down-regulation of Pim-1 led to
cell cycle arrest and reduced the proliferation of SACC
cells, which corroborates results from the CCK-8 assay.
Effect of the Pim-1 siRNA on cell invasion
Figure 6 showed that in both SACC-83 and SACC-LM
cells, the invasion potentials in blank and control siRNA
were not significantly different, while the invasion poten-
tial of the Pim-1 siRNA transfected cells were significantly
decreased compared to the control group. In contrast, the
invasion inhibitory effect by Pim-1 siRNA was more obvi-
ous in SACC-83 cells than in SACC-LM cells.Effect of the Pim-1 siRNA on the mitochondrial function
After transfection by Pim-1 siRNA in both SACC cells,
the JC-1 red fluorescence was reduced while JC-1 green
fluorescence was increased relative to control siRNA
(Figure 7A). Therefore, the data presented a significant
decrease in the red/green fluorescence intensity ratio, in-
dicating a decreased ΔΨm (Figure 7B). This result sug-
gests that the reduction of Pim-1 expression could drive
mitochondrial depolarization.CC cells. A. Crystal violet staining images of invasive SACC-83 and
he number of invaded SACC-83/SACC-LM in control siRNA and Pim-1
-1 siRNA group compared with control siRNA group.
Figure 7 Depolarization of mitochondria membrane induced by Pim-1 siRNA in SACC cells. A. Cells were stained with JC-1 and analyzed
by cytometer after Pim-1 and control siRNA transfection for 72 h. B. Mitochondrial depolarization presented by decrease in the red/green fluorescence
intensity ratio. Results were showed as mean ± SD. p < 0.05, *control siRNA group compared with Pim-1 siRNA group.
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after Pim-1 siRNA transfection
After transfection with Pim-1 siRNA for 72 h, RUNX3,
Cyclin D1 and CDK4 protein expression of both SACC
cells were measured by Western blot. It was showed that
there was a slight increase in RUNX3 level in SACC-83
cell (Figure 8A). Figure 8B illustrated that Pim-1 knock-
down may downregulate the Cyclin D1 and CDK4 pro-
tein expression and contribute to the cellular effects we
identify in this study.
Correlation between Pim-1 and RUNX3 protein levels in
ACC tissues
Immunohistochemical (IHC) staining of Pim-1 and
RUNX3 in ACC tissues is shown in Figure 9. PositiveFigure 8 Pim-1 depletion altered the RUNX3, Cyclin D1 and CDK4 lev
in SACC cells after Pim-1 siRNA transfection. The expression of GAPDH was
expression Cyclin D1 and CDK4 protein in SACC cells after Pim-1 siRNA tranratios of Pim-1 and RUNX3 were 83.33% (45/54) and
20.37% (11/54), respectively. Table 1 showed there is a
significant inverse correlation between the expression of
Pim-1 and RUNX3.
Correlation between the level of Pim-1 and RUNX3 and
the clinical characteristics in ACC tissues
To identify the role of Pim-1 and RUNX3 expression in
ACC, we analyzed the correlation between Pim-1 and
RUNX3 expression in ACC tissues and clinicopathologic
indexes. The IHC staining results are displayed in Figure 7.
Table 2 illustrates that both Pim-1 and RUNX3 levels were
closely associated with T-status and nerve invasion (p <
0.05), but not with gender, age, tumor location, histo-
logical grade type, lymph node involvement or distantels. A. Western blot analysis showed the expression of RUNX3 protein
used as a loading control. B. Western blot analysis showed the
sfection. The expression of β-actin was used as a loading control.
Figure 9 Immunohistochemical (IHC) staining of Pim-1 and RUNX3 in ACC. A. Negative Pim-IHC staining in ACC. B. Positive Pim-1 IHC
staining in ACC. C. Negative RUNX3 IHC staining in ACC. D. Positive RUNX3 IHC staining in ACC. Magnificant factor: ×400.
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more malignant tumors tend to have higher Pim-1 and
lower RUNX3 level.
Survival analysis
Kaplan–Meier survival curves (Figure 10) showed that
Pim-1 level had a weak association with overall survival of
ACC patients (p = 0.091). Patients with lower Pim-1 levels
had a better outcome than that with higher Pim-1 levels.
Discussion
Increasing evidence shows the important role of Pim-1
in many cancers. Various investigations have linked Pim-
1 to aggressive malignant behavior and poor clinical out-
come in many cancer cells, including gastric cancer [17],
prostate cancer [18], esophageal squamous cell carcinoma
[19], breast cancer [20], lung cancer [21], colon cancer [22],
and hematological cancer [23]. However, few studies has
concern the implications of Pim-1 in salivary ACC.
In this study, SACC-83 and SACC-LM cell lines were
used to evaluate the function of Pim-1 in salivary ACC.
After Pim-1 siRNA transfection, the mRNA and protein
levels of Pim-1 were significantly decreased in both cell
lines, suggesting that Pim-1 siRNA inhibits endogenousTable 1 Relationship between the level of Pim-1 and
RUNX3
Variable Patients (total = 54) p-value
Negative Positive
Pim-1 9 45
RUNX3 43 11 0.003Pim-1 expression. CCK-8 assay and colony formation re-
sults revealed that down-regulation of Pim-1 could re-
strain the cell viability of SACC-83 and SACC-LM.
Meanwhile, we use SGI-1776, which was confirmed as a
novel inhibitor of the PIM kinases to test the function of
Pim-1. SGI-1776 is an imidazo [1,2-b] pyridazine com-
pound and have been proved to effectively reduced Pim-1
activity in several researches [24-26]. Our results displayed
that SGI-1776 could evidently induced the SACC cells
growth inhibition. It could be deduced from these results
that Pim-1 is important for cell proliferation in ACC cells.
To disarrange cell cycle progression is one of the cen-
tral features of malignant cancer cells. In the present
study, it was found that G0-G1 phase cells were in-
creased while G2-M phase and S phase cells were de-
creased after Pim-1 siRNA transfection. Furthermore,
we observed the down-regulation of Cyclin D1 and
CDK4 protein expression. Cyclin D1 and CDK4 work to-
gether to form the complex and to promote G1 phase
progression and regulate the cell cycle G1/S transition
[27]. Those data demonstrates that the G0/G1 cell cycle
arrest was induced by knocking down Pim-1 and prob-
ably mediated by Cyclin D1 and CDK4. Annexin V-FITC/
PI and transwell assay results showed that the apoptosis
rates were dramatically ascended and the invasion ability
was significantly reduced after Pim-1 siRNA transfection
in both cell lines. Meanwhile, the mitochondrial dysfunc-
tion indicated by membrane potential decrease after
siRNA transfection in both cells was investigated. These
findings reinstates the oncogenic function of Pim-1 in
ACC cell lines, indicating the important role of Pim-1 in
tumorigenesis of ACC.
Table 2 Relationship between the Pim-1, RUNX3 level and the clinical characteristics
Variable Patients (total = 54) Pim-1 p-value RUNX3 p-value
Negative Positive Negative Positive
Gender Male 23 4 19 1.000 19 4 0.741
Femal 31 5 26 24 7
Age <46 26 3 23 0.495 21 5 1.000
≥46 28 6 22 22 6
T-status T1-2 22 8 14 0.002 14 8 0.036
T3-4 32 1 31 29 3
Tumor location Major salivary 21 4 17 0.723 15 6 0.305
Minor salivary 33 5 28 28 5
Histological type Cribiform 24 4 20 1.000 22 2 0.116
Tubula 12 2 10 8 4
Solid 18 3 15 13 5
Lymph node involvement Yes 9 0 9 0.328 8 1 0.667
No 45 9 36 35 10
Nerve invasion Yes 0 1 29 0.007 28 2 0.007
No 24 8 16 15 9
Distant metastasis Yes 8 0 8 0.326 8 0 0.184
No 46 9 37 35 11
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Pim-1 siRNA could dramatically reduce the invasion cap-
acity of SACC cells. The invasion inhibition effect by the
Pim-1 siRNA was stronger in the SACC-83 cells than in
the SACC-LM cells. The immunohistochemical results
show that Pim-1 level is significantly associated with nerveFigure 10 Kaplan–Meier curve for the relationship between Pim-1 pro
and survival time of ACC patients.invasion in ACC patients. The findings suggest Pim-1 ex-
pression may be a critical marker for ACC invasion.
In 2006, Aho et al. found that the C-terminal part of hu-
man RUNX3 associates with Pim-1 by using the yeast two-
hybrid system [8]. Subsequently, Kim et al. demonstrated
that Pim-1 phosphorylates four Ser/Thr residues within thetein expression which analyzed by immunohistochemistry (IHC)
Zhu et al. Journal of Experimental & Clinical Cancer Research  (2014) 33:114 Page 11 of 12Runt domain and stabilizes RUNX3 protein [7]. In SACC-
83, we observed an increase of RUNX3 protein level after
Pim-1 transfection. In ACC tissues, there was a significant
reverse correlation between the Pim-1 and RUNX3 expres-
sion by IHC evaluation.
Moreover, we investigated the Pim-1 and RUNX3 in
ACC tissues. The IHC results show that both Pim-1 and
RUNX3 levels were significantly associated with T stage
and nerve invasion. Patients with advanced T stage and
nerve invasion had a higher Pim-1 and lower RUNX3 level.
High expression of Pim-1 and low expression of RUNX3
were associated with aggressive tumor behavior. This evi-
dence suggests an importance of the interaction between
Pim-1 and RUNX3 in ACC. As to other clinical features
such as gender, age, tumor location, histological grade type,
lymph node involvement or distant metastasis, we did not
found significant associations between the Pim-1/RUNX3
and them, which might owing to the limitation of the can-
cer quantity and need to be further studied.
Survival analysis indicated that Pim-1 level had a weak
association with overall survival of the ACC patients (p =
0.091). Patients with lower Pim-1 level had a better out-
come than that with higher Pim-1 level. Choi et al. found
that Pim-1 expression might be used as a possible prog-
nostic factor in laryngeal squamous cell carcinoma [28].
Peng et al. presented that expression of Pim-1 in tumors,
tumor stroma, and tumor-adjacent mucosa could indicate
the prognosis of colon cancer patients [29]. Moreover, Jin
et al. confirmed that overexpression of Pim-1 associated
with poor prognosis of non-small cell lung cancer [21]. Our
findings corroborate the findings of these studies, yet more
studies will be needed to define mechanisms of Pim-1 ex-
pression and function in ACC.
Conclusion
The present study demonstrates that Pim-1 is important
in cell proliferation, apoptosis, cell cycle, and invasion in
both SACC-83 and SACC-LM cell lines. Pim-1 and
RUNX3 levels were negative relevant and significantly
associated with T-stage and nerve invasion in the ACC
tissues. This study approves the oncogenic role of Pim-1
in ACC. The findings also suggest that Pim-1 may serve
as a neoteric therapeutic target and potential prognostic
marker for ACC cancer.
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